Sheena K. Aurora - Search Results

Year	Number of Results
2002	4
2003	1
2005	3
2006	2
2007	3
2009	7
2010	14
2011	13
2012	3
2013	4
2014	3
2015	6
2016	3
2017	6
2018	7
2019	15
2020	10
2021	7
2022	4
2023	5
2024	0

1

Baseline demographics and disease characteristics of patients with episodic or chronic cluster headache: data from two phase 3 randomized clinical trials in Europe and North America.

Jensen RH, Tassorelli C, Myers Oakes TM, Bardos JN, Zhou C, Dong Y, Aurora SK, Martinez JM. Jensen RH, et al. Among authors: aurora sk. Front Neurol. 2023 Dec 15;14:1293163. doi: 10.3389/fneur.2023.1293163. eCollection 2023. Front Neurol. 2023. PMID: 38162453 Free PMC article.

2

New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay.

McConnachie L, Goadsby PJ, Vann RE, Ray S, Shrewsbury SB, Aurora SK. McConnachie L, et al. Among authors: aurora sk. Front Neurol. 2023 Nov 21;14:1282846. doi: 10.3389/fneur.2023.1282846. eCollection 2023. Front Neurol. 2023. PMID: 38073648 Free PMC article.

3

The Gut-brain Connection and Episodic Migraine: an Update.

Nguyen L, Hindiyeh N, Ray S, Vann RE, Aurora SK. Nguyen L, et al. Among authors: aurora sk. Curr Pain Headache Rep. 2023 Nov;27(11):765-774. doi: 10.1007/s11916-023-01175-6. Epub 2023 Oct 4. Curr Pain Headache Rep. 2023. PMID: 37792173 Free PMC article. Review.

4

Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.

Wang VS, Kosman J, Yuan H, Lauritsen C, Shrewsbury S, Aurora SK, Hopkins M, Silberstein S. Wang VS, et al. Among authors: aurora sk. Headache. 2023 Oct;63(9):1251-1258. doi: 10.1111/head.14636. Epub 2023 Sep 23. Headache. 2023. PMID: 37740562

5

INP104: a drug evaluation of a nonoral product for the acute treatment of migraine.

Starling AJ, Mallick-Searle T, Shrewsbury SB, Aurora SK. Starling AJ, et al. Among authors: aurora sk. Pain Manag. 2023 May;13(5):283-298. doi: 10.2217/pmt-2022-0063. Epub 2023 Jun 20. Pain Manag. 2023. PMID: 37337861 Free article. Review.

6

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.

Tepper SJ, Ailani J, Ray S, Hirman J, Shrewsbury SB, Aurora SK. Tepper SJ, et al. Among authors: aurora sk. J Headache Pain. 2022 Nov 22;23(1):148. doi: 10.1186/s10194-022-01519-4. J Headache Pain. 2022. PMID: 36414952 Free PMC article. Review.

7

Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action.

Cooper W, Ray S, Aurora SK, Shrewsbury SB, Fuller C, Davies G, Hoekman J. Cooper W, et al. Among authors: aurora sk. J Aerosol Med Pulm Drug Deliv. 2022 Dec;35(6):321-332. doi: 10.1089/jamp.2022.0005. Epub 2022 Sep 14. J Aerosol Med Pulm Drug Deliv. 2022. PMID: 36108289 Free PMC article. Review.

8

Reductions in acute medication use and healthcare resource utilization in patients with chronic migraine: a secondary analysis of a phase 3, randomized, double-blind, placebo-controlled study of galcanezumab with open-label extension (REGAIN).

Tobin JA, Joshi S, Ford JH, Nichols RM, Foster SA, Ruff D, Detke HC, Aurora SK. Tobin JA, et al. Among authors: aurora sk. J Med Econ. 2022 Jan-Dec;25(1):1030-1038. doi: 10.1080/13696998.2022.2109335. J Med Econ. 2022. PMID: 35971655 Free article. Clinical Trial.

9

Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study.

Pozo-Rosich P, Detke HC, Wang S, Doležil D, Li LQ, Aurora SK, Reuter U. Pozo-Rosich P, et al. Among authors: aurora sk. Curr Med Res Opin. 2022 May;38(5):731-742. doi: 10.1080/03007995.2022.2059975. Epub 2022 Apr 15. Curr Med Res Opin. 2022. PMID: 35392739 Clinical Trial.

10

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Ament M, et al. Among authors: aurora sk. J Headache Pain. 2021 Aug 26;22(1):100. doi: 10.1186/s10194-021-01307-6. J Headache Pain. 2021. PMID: 34445967 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year